RNAte

Introduction to RNAte's Quality Specialist - Tony Cardno At RNAte, quality and adhering rigorously to compliance standards are of utmost importance. 18 months ago, we employed a Quality Specialist to build and implement a Quality Management System in accordance with ISO/IEC 17025 Testing and Quality and Good Clinical Laboratory Practice (GCLP) standards. Tony comes with a wide range of scientific and business experience, first working in drug discovery at Pfizer in England, then leading his own High Throughput Screening campaign against an HIV mRNA target at the Walter and Eliza Hall Institute of Medical Research | WEHI. He then automated and ran various high throughput G Protein-Coupled Receptor (GPCR) targeted screening assays at the Monash Institute of Pharmaceutical Sciences | MIPS, contributing to R&D at CSL Behring Plasma Product Development, and adapting clients' molecular assays to microfluidics at Schott MiniFab. Tony also complements his scientific expertise with time spent working in financial services roles in Sydney and Melbourne, latterly working to understand and optimise business processes. Tony's unique combination of rigorous scientific expertise and business acumen has been instrumental in establishing RNAte's quality framework, ensuring we deliver reliable results to our clients. Hudson Institute of Medical Research #NATA #RNATechnology #mRNA #QualityInScience #ClinicalResearchExcellence

RNAte achieves major milestone in 2025: First in Australia accredited for RNA medicine testing under ISO/IEC 17025:2017 and GCLP standards. This positions RNAte at the forefront of RNA tech innovation, delivering trusted results for RNA based vaccines, therapeutics, and clinical translation. 🏆 Looking forward to more achievements via collaborations and partnerships in 2026!

RNAte Leads the Way: The First in Australia Accredited under ISO/IEC 17025:2017 and GCLP for RNA Medicines The RNAte Technology Platform has been officially accredited by the National Association of Testing Authorities (NATA), Australia, under ISO/IEC 17025:2017 and Good Clinical Laboratory Practice (GCLP) standards — becoming the first facility in Australia accredited for the testing of RNA medicines. This world-class accreditation confirms RNAte’s technical competence, reliability, and commitment to operating at the highest international quality standards. It also aligns RNAte’s operations with the principles of ISO 9001, reinforcing a culture of continuous improvement and quality management across all activities. This milestone positions RNAte at the forefront of RNA technology innovation and quality assurance, setting a new benchmark and delivering trusted, high-quality results that advance vaccines, therapeutics, and clinical translation in Australia and globally. Hudson Institute of Medical Research #NATA #RNATechnology #mRNA #QualityInScience #ClinicalResearchExcellence

Our team building event – taking on space aliens and good food! The RNAte team recently took on a Virtual Reality (VR) battle with space aliens, followed by a meal at a local restaurant.  A great way to celebrate our accomplishments and promote team bonding outside of operations. Hudson Institute of Medical Research #NATA #RNATechnology #mRNA #QualityInScience #ClinicalResearchExcellence

A valuable week of RNA technology, connections, and collaboration. Dr Esther Ling, PhD AAICD and A/Prof Michael Gantier represented RNAte at the 4th Advances in mRNA Science (AIMS) meeting in Melbourne, engaging in key discussions on the future of RNA therapeutics. A/Prof Gantier presented last year, and this year our collaborator Prof Gavin Painter took the stage, highlighting the strength of our Trans-Tasman collaboration in advancing RNA vaccines and therapeutics. Over the past year, we’ve grown the team and earned NATA accreditation for ISO/IEC 17025:2017 and Good Clinical Laboratory Practice (GCLP) standards, becoming the first facility in Australia accredited for the testing of RNA medicines It was great to meet with our community, seeing great science and discussions on how the mRNA therapeutic space is growing in Australasia.  We look forward to the next meeting! Hudson Institute of Medical Research Te Kāuru — The Ferrier Research Institute #NATA #RNATechnology #mRNA #QualityInScience #ClinicalResearchExcellence

RNAte Leads the Way: The First in Australia Accredited under ISO/IEC 17025:2017 and GCLP for RNA Medicines The RNAte Technology Platform has been officially accredited by the National Association of Testing Authorities (NATA), Australia, under ISO/IEC 17025:2017 and Good Clinical Laboratory Practice (GCLP) standards — becoming the first facility in Australia accredited for the testing of RNA medicines. This world-class accreditation confirms RNAte’s technical competence, reliability, and commitment to operating at the highest international quality standards. It also aligns RNAte’s operations with the principles of ISO 9001, reinforcing a culture of continuous improvement and quality management across all activities. This milestone positions RNAte at the forefront of RNA technology innovation and quality assurance, setting a new benchmark and delivering trusted, high-quality results that advance vaccines, therapeutics, and clinical translation in Australia and globally. Hudson Institute of Medical Research #NATA #RNATechnology #mRNA #QualityInScience #ClinicalResearchExcellence

We were honoured to welcome the Minister for Economic Growth and Jobs and Minister of Finance, The Hon. Danny Pearson, to the RNAte Laboratory at Hudson Institute of Medical Research on 23 October 2025. The visit was a fantastic opportunity to showcase how our team is advancing RNA-based research and therapeutic development here in Victoria. Minister Pearson’s interest in local innovation and his support for the growing RNA ecosystem highlight the importance of investing in advanced biotechnology capability within Australia. As a NATA ISO/IEC 17025 Testing and Calibration and Good Clinical Laboratory Practice (GCLP) accredited facility, RNAte provides high-quality, reliable analytical services that support the safe and effective development of RNA technologies , from early discovery through to clinical translation. We’re proud to empower the global RNA industry with world-leading expertise in innate immunity and inflammation, accelerating RNA translation and commercial readiness of mRNA therapeutics and vaccines.. Thank you, Minister and your dedicated team, for your continued support. Your investment in RNAte is building a strong sovereign RNA capability right here in Australia. Hudson Institute of Medical Research #mRNA #mRNAVictoria #Biotechnology, #Innovation

https://lnkd.in/g7bNPDyQ